Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia (CARE-HK in HF Registry)

NCT04864795 is registered in ClinicalTrials.gov with Vifor (International) Inc. as lead sponsor.

NCT NCT04864795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04864795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia (CARE-HK in HF Registry)
Lead sponsor
Vifor (International) Inc.
Phase
Observational
Overall status
Completed
Start date
April 19, 2021
Completion date
August 30, 2024
Enrollment
2,636 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, hyperkalemia